February 2011, Vol. 101, No. 2 SAMJ Human immunodeficiency virus (HIV) infection is, with advancing immunosuppression, a risk factor for the development of heart failure due to dilated cardiomyopathy. 1 In Africa, cross-sectional echocardiographic studies of HIV-infected individuals suggest a prevalence of cardiomyopathy varying from 9% in ambulant persons to 57% in hospitalised patients. 2 Patients with HIV infection and dilated cardiomyopathy have a much worse prognosis than HIVpositive individuals with normal cardiac function. The negative prognostic impact of cardiac dysfunction in people living with HIV is reflected by a median survival to AIDS-related death of 101 days in patients with cardiomyopathy compared with 472 days in patients with a normal heart by echocardiography at a similar stage of infection without antiretroviral treatment. 3 The cause of cardiomyopathy in black African patients infected with HIV remains largely unknown, although several predisposing factors have been identified. 1, 4 These include low socio-economic status, longer duration of HIV infection, lower CD4 cell count, higher viral load, low plasma selenium level, and advanced stage of HIV disease. 5 Malnutrition has been postulated to be a contributory factor in the development of cardiomyopathy in HIV-infected individuals, but to the best of our knowledge the association of nutritional status with HIV-associated cardiomyopathy has not been established in appropriately designed studies. 5 We conducted a cross-sectional study among HIV-infected adults to determine whether there is an association between nutritional status, measured by simple anthropometric criteria that can be applied in routine clinical practice, and HIV-related cardiomyopathy. This investigation of the relationship between nutritional status and cardiomyopathy in HIV-positive patients may be relevant in the development of new therapeutic strategies, including restoration of adequate myocyte nutrition as a goal in the treatment of patients suffering from HIV-related heart failure. 
Methods

Design
Selection of participants
HIV-positive patients with and without cardiomyopathy were recruited from HIV clinics at Groote Schuur, New Somerset and G F Jooste Hospitals in Cape Town. Clinic attendees over the age of 18 years were invited to attend the Cardiac Clinic at Groote Schuur Hospital for clinical evaluation and examination by twodimensional guided M-mode echocardiography to identify those with cardiomyopathy. The two groups were matched for ethnicity as part of a study of genetic risk factors for cardiomyopathy in people with HIV infection. 6 One experienced echocardiographer carried out all the echocardiographic examinations, using a calibrated ultrasound machine with a 2.5 MHz transducer with subjects in the left lateral position. The echocardiographic examinations were read by one cardiologist (BMM).
Patients with dilated cardiomyopathy (a fractional shortening of <25% and left ventricular internal dimension >112% of predicted, according to Henry's formula) or patients with left ventricular dysfunction (a fractional shortening of <25% and normal ventricular Results. 7 Patients with valvular heart disease, hypertension, ischaemic, pericardial or congenital heart disease, diabetes or alcoholic cardiomyopathy and women who fulfilled the criteria for peripartum cardiomyopathy were excluded. Treatment with antiretroviral agents that have been implicated in cardiomyopathy 8 was also grounds for exclusion. Normal heart function was confirmed by echocardiography in all individuals in the comparison group.
Laboratory tests
CD4 cell counts were obtained by lymphocyte immunophenotyping using a flow cytometer in the Immunology Laboratory at Groote Schuur Hospital. The HIV viral load was measured by a quantitative polymerase chain reaction assay of viral genomic RNA using the Nasba kit in the Division of Virology at the University of Cape Town.
Assessment of nutritional status
The following anthropometric measurements were taken by the same observer: body weight (on an electronic scale to the nearest 0.2 kg), height (on a portable stadiometer to the nearest 1 mm, patient without shoes, feet parallel), mid-upper arm circumference (MUAC) (measured to the nearest 1 mm on the left arm using a standardised measuring tape -normal range is >232 mm for women and >243 mm for men), and triceps skinfold thickness (TSF) (to the nearest 0.2 mm using a Harpender caliper). Body mass index (BMI) (weight/height 2 , normal range 18.5 -24.9) and bone-free arm muscle area (BF-AMA) (MUAC-(3.14×TSF)) were calculated.
9,10
Statistical methods
Categorical variables were compared using the χ 2 test and continuous variables using the non-parametric Mann-Whitney test. The multivariate stepwise logistic regression model was used to identify independent anthropometric risk factors for cardiomyopathy. All tests were double-sided, and a p-value of <0.05 was considered significant.
Results
The clinical characteristics and nutritional status of the 17 patients with HIV-associated cardiomyopathy and the 18 HIV-infected individuals without cardiomyopathy are presented in Table I 
Discussion
We showed that a lower BMI is associated with cardiomyopathy in people living with HIV. HIV infection profoundly affects nutritional status because it is associated with poor appetite, impaired nutrient absorption, increased basal metabolic rate and opportunistic infections.
11 Under-nutrition in HIV patients is manifested by weight loss, loss of lean body mass and micronutrient deficiencies. We compared two groups of HIV-infected individuals who were well matched for the stage of HIV disease. The lower BMI is therefore likely to be independent of HIV infection, and linked to the cardiac disease.
Cardiac function is both affected by nutrition and can affect nutritional status. In a malnourished state, relative cardiac sparing occurs -this is especially apparent in chronic disease. 11 Cardiac sparing occurs to preserve left ventricular function -even in patients with severe protein energy malnutrition, ventricular mass decreases but the ratio of ventricular mass to body weight remains constant. Heart disease can also have an adverse effect on nutritional status. Chronic heart dysfunction can result in cardiac cachexia, an inappropriate use of lean body mass instead of body fat that results in muscle wasting.
The major limitation of this study is that it cannot determine whether the lower BMI in HIV-associated cardiomyopathy is part of the causal pathway of cardiomyopathy or an effect of the cardiac dysfunction. Furthermore, the potential role of micronutrient deficiency in the pathogenesis of the cardiomyopathy was not investigated. When attempting to determine nutritional determinants of cardiomyopathy, it is important to measure micronutrient levels of substances such as selenium, which are implicated in ventricular function. 12 Although selenium deficiency in healthy humans is uncommon, studies have documented a decline in selenium levels in the general HIV-infected population, possibly owing to the trapping of selenium by a selenoprotein encoded by the proviral genome. 13, 14 Low levels of selenium increase the ability of the Coxsackie virus to cause cardiac damage and ventricular dysfunction. 12 The role of selenium in the pathogenesis of HIV-associated cardiomyopathy has been investigated. 5, 14, 15 Chariot et al. investigated the involvement of antioxidant deficiencies in the occurrence of cardiac involvement in HIV-infected patients. 16 Selenium status was significantly lower in the patients compared with the controls. Selenium supplementation resulted in echocardiographic improvement. There was an improvement of cardiac function after selenium supplementation in case reports involving paediatric AIDS patients. 15 Finally, low selenium levels have been shown to be a significant factor in the development of HIV-associated cardiomyopathy in black African patients. 5 This study extends the observations of micronutrient deficiency in HIV-associated cardiomyopathy to include lower BMI, a simple clinical measure of nutritional status that can be applied in resourcepoor circumstances of sub-Saharan Africa, which is the epicentre of the HIV/AIDS epidemic in the world. Although micronutrient measures were not performed in this study, our results are consistent with the observation that micronutrient deficiency is predictive of cardiomyopathy in people who are living with HIV infection. These preliminary findings, taken together with the small trials of selenium supplementation in HIV-associated cardiomyopathy, have important implications for the development of new therapies in this field. The time has come to consider the role of nutritional interventions in HIV-associated cardiomyopathy, including the restoration of adequate myocyte nutrition as a goal in treating patients suffering from HIV-related heart failure. 
